Invention Grant
- Patent Title: Benzimidazole carboxamides as raf kinase inhibitors
- Patent Title (中): 苯并咪唑甲酰胺作为raf激酶抑制剂
-
Application No.: US10564184Application Date: 2004-06-11
-
Publication No.: US07691870B2Publication Date: 2010-04-06
- Inventor: Hans-Peter Buchstaller , Matthias Wiesner , Frank Zenke , Christiane Amendt , Matthias Grell , Christian Sirrenberg
- Applicant: Hans-Peter Buchstaller , Matthias Wiesner , Frank Zenke , Christiane Amendt , Matthias Grell , Christian Sirrenberg
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Arent Fox LLP
- Priority: EP03015583 20030711
- International Application: PCT/EP2004/006337 WO 20040611
- International Announcement: WO2005/004863 WO 20050120
- Main IPC: C07D401/00
- IPC: C07D401/00 ; A61K31/505 ; A01N43/64
Abstract:
The present invention relates to benzimidazole carboxamides of formula I, the use of the compounds of formula I of as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of pharmaceutical compositions and methods of treatment, comprising administering said pharmaceutical compositions to a patients.
Public/Granted literature
- US20070093532A1 Benzimidazole carboxamides as raf kinase inhibitors Public/Granted day:2007-04-26
Information query
